 SOMERSET, N.J.--BUSINESS WIRE--Legend Biotech Corporation NASDAQ: LEGN Legend Biotech, a global clinical-stage biopharmaceutical company engaged in the discovery and development of novel cell therapies for oncology and other indications, announced today that it has appointed Dr. Li Zhu to Legend Biotechs Board of Directors. Dr. Zhu will serve as a Class III director. In addition, Dr. Fangliang Zhang tendered his resignation from the Board of Directors of Legend Biotech and its committe 